Gadolinium-based contrast agent accumulates in the brain even in subjects without severe renal dysfunction: Evaluation of autopsy brain specimens with inductively coupled plasma mass spectroscopy

Radiology

Volumn 276, Issue 1, 2015, Pages 228-232

  Kanda, Tomonori ^a   Fukusato, Toshio ^a   Matsuda, Megumi ^a   Toyoda, Keiko ^a   Oba, Hiroshi ^a   Kotoku, Jun'ichi ^a   Haruyama, Takahiro ^a   Kitajima, Kazuhiro ^b   Furui, Shigeru ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM;

ACUTE KIDNEY FAILURE; ARTICLE; AUTOPSY; BIOACCUMULATION; BRAIN TISSUE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DENTATE NUCLEUS; DISEASE SEVERITY; DRUG BRAIN LEVEL; FRONTAL LOBE; GLOBUS PALLIDUS; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DYSFUNCTION; MASS SPECTROMETRY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WHITE MATTER; ATOMIC ABSORPTION SPECTROMETRY; BRAIN; KIDNEY DISEASE; METABOLISM; PATHOLOGY; SEVERITY OF ILLNESS INDEX; TISSUE DISTRIBUTION;

AUTOPSY; BRAIN; CONTRAST MEDIA; GADOLINIUM; HUMANS; KIDNEY DISEASES; SEVERITY OF ILLNESS INDEX; SPECTROPHOTOMETRY, ATOMIC; TISSUE DISTRIBUTION;

EID: 84936147184     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2015142690     Document Type: Article

References (16)

1. Hao D, Ai T, Goerner F, Hu X, Runge VM, Tweedle M. MRI contrast agents: basic chemistry and safety. J Magn Reson Imaging 2012;36(5):1060-1071.
2. Runge VM. Safety of approved MR contrast media for intravenous injection. J Magn Reson Imaging 2000;12(2):205-213.
3. Idée JM, Port M, Robic C, Medina C, Sabatou M, Corot C. Role of thermodynamic and kinetic parameters in gadolinium chelate stability. J Magn Reson Imaging 2009;30(6):1249-1258.
4. Aime S, Caravan P. Biodistribution of gadolinium-based contrast agents, including gadolinium deposition. J Magn Reson Imaging 2009;30(6):1259-1267.
5. Kanda T, Ishii K, Kawaguchi H, Kitajima K, Takenaka D. High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material. Radiology 2014;270(3):834-841.
6. Kanda T, Osawa M, Oba H, et al. High signal intensity in dentate nucleus on unenhanced T1-weighted MR images: association with linear versus macrocyclic gadolinium chelate administration. Radiology 2015 Jan 27:140364. [Epub ahead of print]
7. Errante Y, Cirimele V, Mallio CA, Di Lazzaro V, Zobel BB, Quattrocchi CC. Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation. Invest Radiol 2014;49(10):685-690.
8. Sanyal S, Marckmann P, Scherer S, Abraham JL. Multiorgan gadolinium (Gd) deposition and fibrosis in a patient with nephrogenic systemic fibrosis: an autopsy-based review. Nephrol Dial Transplant 2011;26(11):3616-3626.
9. Christensen KN, Lee CU, Hanley MM, Leung N, Moyer TP, Pittelkow MR. Quantification of gadolinium in fresh skin and serum samples from patients with nephrogenic systemic fibrosis. J Am Acad Dermatol 2011;64(1):91-96.
10. Gibby WA, Gibby KA, Gibby WA. Comparison of Gd DTPA-BMA (Omniscan) versus Gd HP-DO3A (ProHance) retention in human bone tissue by inductively coupled plasma atomic emission spectroscopy. Invest Radiol 2004;39(3):138-142.
11. White GW, Gibby WA, Tweedle MF. Comparison of Gd(DTPA-BMA) (Omniscan) versus Gd(HP-DO3A) (ProHance) relative to gadolinium retention in human bone tissue by inductively coupled plasma mass spectroscopy. Invest Radiol 2006;41(3):272-278.
12. Darrah TH, Prutsman-Pfeiffer JJ, Poreda RJ, Ellen Campbell M, Hauschka PV, Hannigan RE. Incorporation of excess gadolinium into human bone from medical contrast agents. Metallomics 2009;1(6):479-488.
13. Xia D, Davis RL, Crawford JA, Abraham JL. Gadolinium released from MR contrast agents is deposited in brain tumors: in situ demonstration using scanning electron microscopy with energy dispersive X-ray spectroscopy. Acta Radiol 2010;51(10):1126-1136.
14. McDonald RJ, McDonald JS, Kallmes DF, et al. Intracranial gadolinium deposition after contrast-enhanced MR imaging. Radiology 2015 Mar 5:150025. [Epub ahead of print]
15. Sieber MA, Lengsfeld P, Frenzel T, et al. Preclinical investigation to compare different gadolinium-based contrast agents regarding their propensity to release gadolinium in vivo and to trigger nephrogenic systemic fibrosis-like lesions. Eur Radiol 2008;18(10):2164-2173.
16. Sieber MA, Pietsch H, Walter J, Haider W, Frenzel T, Weinmann HJ. A preclinical study to investigate the development of nephrogenic systemic fibrosis: a possible role for gadolinium-based contrast media. Invest Radiol 2008;43(1):65-75.